ArticleOncotarget2017

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.